The Natural Quassinoid Brusatol Enhances Venetoclax Efficacy and Overcomes Resistance in Myeloid Leukemias.

Compared with continuous daily administration, this intermittent schedule led to only a modest extension of survival that did not reach statistical significance in the MOLM‐14 xenograft model (Figure 6B and Figure S5A,B ).

also in 111,027 other papers